Mega-deals drove up global M&A value 30% to US$4.28 trillion in 2015, with robust M&A activity expected to continue in 2016, according to Deal Drivers Americas: 2015 Full-Year Edition.
Mega-deals, such as Pfizer’s US$183.7 billion deal for Ireland’s Allergan, contributed to a 30% rise in global M&A value in 2015. Dealmaking had an especially strong year in the US, with overall deal value rising 40% to reach a record high of almost US$2 trillion. Valuations jumped across sectors globally—buyers paid 24.3x EBITDA for technology acquisitions and 18.8x EBITDA for pharma, medical and biotech firms. Yet equity markets stumbled worldwide at the start of 2016, breeding caution among dealmakers. According to this report, brought to you by Mergermarket in association with Merrill Corporation, major acquisitions and consolidation are expected to continue among players in established technologies such as cloud computing and Big Data. Meanwhile, a new wave of innovation could drive the mid-market in areas such as the Internet of Things, fintech and marketing tech. In addition, private equity firms in the Americas are expected to be highly active in 2016, targeting mid-sized tech, post-acute healthcare, high-growth retail and E&P companies. Find out what other sectors and regions—from financial services and energy to Canada and Latin America—are expected to drive M&A activity in 2016.
- Americas heat chart, tracking deal trends by sector and region
- Top 20 deals by region for 2015, including bidder, target, sector, vendor and deal value
- Top 20 financial, legal and PR advisors for 2015, ranked by value and volume
- Top 15 deals by sector for 2015, including bidder, target, vendor and deal value